A (continued)
- antagonist
- anterior
- anterior mediastinotomy
- anterior mediastinum
- anterior pelvic exenteration
- anterior urethral cancer
- anthracenedione
- anthracycline
- anthraquinone
- anti-CD19 immunotoxin
- anti-CD22 immunotoxin
- anti-CEA antibody
- anti-EpCAM-Pseudomonas-exotoxin fusion protein
- anti-idiotype vaccine
- anti-IGF1R recombinant monoclonal antibody MK-0646
- anti-inflammatory
- anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3
- anti-TGF-beta monoclonal antibody GC1008
- anti-TRAIL R1-mAb
- anti-TRAIL R2 mAb HGS-ETR2
A (continued)
- anti-VEGFR monoclonal antibody
- anti-VEGFR-2 fully human monoclonal antibody IMC-1121B
- antiandrogen
- antiandrogen therapy
- antiangiogenesis
- antiangiogenic
- antianxiety agent
- antiapoptotic
- antibacterial
- antibiotic
- antibody
- antibody therapy
- antibody-dependent cell-mediated cytotoxicity
- antibody-dependent cellular cytotoxicity
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticarcinogenic
- anticoagulant
- anticonvulsant